ACENOCOUMAROL OR WARFARIN: WHICH IS THE CLINICIAN'S ALLY?
Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic
disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms
of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin
proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.
Keywords: Thrombosis, Bleeding, Antiphospholipid antibody syndrome, Anticoagulant, International normalized ratio.
Undas A, Ciesla-Dul M, ZÃ³lcinski M, Tracz W. Switching from
acenocoumarol to warfarin in patients with unstable anticoagulation
and its effect on anticoagulation control. Pol Arch Med Wewn
Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G,
et al. Pharmacology and management of the vitamin K antagonists:
American College of Chest Physicians Evidence-Based Clinical
Practice Guidelines (8
Edition). Chest 2008;133 Suppl 6:160S-98.
Gurwitz JH, Avorn J, Ross-Degnan D, Choodnovskiy I, Ansell J. Aging
and the anticoagulant response to warfarin therapy. Ann Intern Med
Sconce EA, Khan TI, Wynne HA, Avery P, Monkhouse L, King BP,
et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and
patient characteristics upon warfarin dose requirements: Proposal for a
new dosing regimen. Blood 2005;106(7):2329-33.
Beinema M, Brouwers JR, Schalekamp T, Wilffert B. Pharmacogenetic
differences between warfarin, acenocoumarol and phenprocoumon.
Thromb Haemost 2008;100(6):1052-7.
Barcellona D, Vannini ML, Fenu L, Balestrieri C, Marongiu F.
Warfarin or acenocoumarol: Which is better in the management of oral
anticoagulants? Thromb Haemost 1998;80(6):899-902.
How to Cite
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.